EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 10 November 2021

How pharmaceutical companies are helping the fight against climate change

Building a healthier and more environmentally sustainable future: a case-study from Takeda
09 November 2021

The pharmaceutical industry contributes to a healthy environment while demonstrating leadership in mitigating climate... Read more

Podcast: How is the pharmaceutical industry contributing to a healthy environment?
31 May 2021

Welcome to 19 Conversations Read more

The impact of innovation

Over the next 5-10 years, many breakthrough innovations will help address unmet need in many disease areas and bring benefits to patients and society.

Discover more on efpia.eu

mRNA vaccines for brain cancer
mRNA technology gave us the first COVID-19 vaccine and it could be used in the future to fight cancer Read more

Gene therapies for rare diseases
#WeWontRest until we can cure rare disease such as haemophilia Read more

Events

Pandemic Prevention: how Europe can lead the fight against AMR
16 November 2021 (Virtual event)

The COVID-19 pandemic took the world by surprise. An AMR induced pandemic will not. Read more

Clinical Trial Disclosure & Data Transparency Conference
16 November 2020 (Virtual event)

Organised by DIA Read more

Cancer Control in Europe: Finding Sustainable Solutions
13 December 2021 (Ljubljana & Online)

Final conference of the Joint Action on Innovative Partnership for Action Against Cancer (iPAAC JA) Read more

10th ACCELERATE Paediatric Oncology Conference
10 February 2022 (Virtual event)

Last days to register! Read more

AMR: Let's find the solutions

Despite the huge societal costs of AMR, there is no viable market for new antibiotics. Let’s create an environment where we champion innovation and antibiotic R&D.

What we are reading

IMI is looking for a Scientific Project Officer
On 10 November 2021 (IMI)

Deadline is Monday 15 November 2021. Read more

5 Things to know about the COVID-19 vaccines
On 10 November 2021 (Vaccines Europe)

The situation around the COVID-19 pandemic is evolving constantly Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu